Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
This intro examines risk profiles for index vs target date funds, offering a clear take on volatility, diversification, and potential drawdowns.
24,893 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Trump signals a deal with Iran could be signed this weekend, but Tehran cautions that no final agreement exists. Medi...
As 2026 unfolds, social security changes still coming could affect your COLA, benefits, taxes, and how you reach the ...
Bitcoin’s on-chain metrics point to a bitcoin network activity dramatic rebound, as daily transactions climb while th...
A Goldman Sachs strategist warns that leverage is rising across retail investors, hedge funds, and leveraged ETFs, po...
Investors ditching magnificent group are chasing a fresh AI-led cohort dubbed MANGOS, with Meta, Alphabet and NVIDIA ...
A bold contrarian wager on semiconductors has underperformed as AI demand sustains a rally. Leveraged, daily-reset fu...
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...
Dubai's property market is cooling as buyers pull back and prices fall. Analysts weigh whether the dip is a temporary...
A star couple stepping onto the red carpet reveals more than fashion. It exposes smart money moves about budgeting fo...
Palantir posted solid Q1 2026 growth, but the stock fell as investors priced in a valuation reset and AI competition....
U.S. equities wrapped an eight-week surge led by tech giants, erasing early-2026 losses. Investors weigh AI-driven ea...